Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Arguedas

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Vaccine|June 19, 2009
Understanding the link between pneumococcal serotypes and invasive diseaseCarolina Soley, Adriano Arguedas
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination for acute otitis mediaAdriano Arguedas, Carolina Soley
Expert Review of Anti-Infective Therapy|October 7, 2005
Single-dose azithromycin for the treatment of children with acute otitis mediaCarolin A Soley, Adriano Arguedas
The Pediatric Infectious Disease Journal|February 11, 2004
Single dose azithromycin for the treatment of uncomplicated otitis mediaAdriano Arguedas, Cecilia Loaiza, Carolina Soley
Vaccine|September 8, 2011
Prevenar experienceAdriano Arguedas, Carolina Soley, Arturo Abdelnour
The New England Journal of Medicine|January 1, 2010
Responses to 2009 H1N1 vaccine in children 3 to 17 years of ageAdriano Arguedas, Carolina Soley, Kelly Lindert
The Pediatric Infectious Disease Journal|May 8, 2004
Potential role of fluoroquinolone therapy in childhood otitis mediaRon Dagan, Adriano Arguedas, Urs B Schaad
Vaccine|May 19, 2009
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccinesGail L Rodgers, Adriano Arguedas, Robert Cohen, et al.
Journal of Sports Sciences|March 17, 2022
Acute caffeine supplementation and live match-play performance in team-sports: A systematic review (2000-2021)Adriano Arguedas-Soley, Isobel Townsend, Aaron Hengist, et al.
Vaccine|August 1, 2009
Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]Gail L Rodgers, Adriano Arguedas, Robert Cohen, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Vaccine|June 19, 2009
Understanding the link between pneumococcal serotypes and invasive diseaseCarolina Soley, Adriano Arguedas
Lancet (London, England)|June 13, 2006
Pneumococcal vaccination for acute otitis mediaAdriano Arguedas, Carolina Soley
Expert Review of Anti-Infective Therapy|October 7, 2005
Single-dose azithromycin for the treatment of children with acute otitis mediaCarolin A Soley, Adriano Arguedas
The Pediatric Infectious Disease Journal|February 11, 2004
Single dose azithromycin for the treatment of uncomplicated otitis mediaAdriano Arguedas, Cecilia Loaiza, Carolina Soley
Vaccine|September 8, 2011
Prevenar experienceAdriano Arguedas, Carolina Soley, Arturo Abdelnour
The New England Journal of Medicine|January 1, 2010
Responses to 2009 H1N1 vaccine in children 3 to 17 years of ageAdriano Arguedas, Carolina Soley, Kelly Lindert
The Pediatric Infectious Disease Journal|May 8, 2004
Potential role of fluoroquinolone therapy in childhood otitis mediaRon Dagan, Adriano Arguedas, Urs B Schaad
Vaccine|May 19, 2009
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccinesGail L Rodgers, Adriano Arguedas, Robert Cohen, et al.
Journal of Sports Sciences|March 17, 2022
Acute caffeine supplementation and live match-play performance in team-sports: A systematic review (2000-2021)Adriano Arguedas-Soley, Isobel Townsend, Aaron Hengist, et al.
Vaccine|August 1, 2009
Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740]Gail L Rodgers, Adriano Arguedas, Robert Cohen, et al.
Pageof 9